Suppr超能文献

C反应蛋白在新生儿败血症中的预测价值。

Predictive value of C-reactive protein in neonatal septicaemia.

作者信息

Adhikari M, Coovadia H M, Coovadia Y M, Smit S Y, Moosa A

出版信息

Ann Trop Paediatr. 1986 Mar;6(1):37-40. doi: 10.1080/02724936.1986.11748408.

Abstract

The following non-specific indices of infection were studied in septicaemic and non-septicaemic babies: haemoglobin, total white blood cell count, differential white count, ESR, platelet count, C-reactive protein (CRP), serum immunoglobulins, plasma C3 and haptoglobin. Forty-three low-birthweight (LBW) infants with clinical features suggesting septicaemia were investigated; blood cultures were positive in 19 and negative in 24. The mortality was 53% in the culture-positive and 13% in the culture negative group. Comparisons between the two groups of babies showed that the CRP titre (measured by Latex agglutination) was the only reliable non-specific indicator of infection. The titre was elevated more often in culture positive (16/19) than culture negative (7/17) babies (P less than 0.001). The CRP titre (Mean +/- 2 S.D.) was 15.75 +/- 12 in blood culture positive and 6.13 +/- 11.72 in culture negative neonates respectively (P less than 0.0004). Positive CRP titres were found in 5 of 20 healthy controls (4 +/- 8.4). Sequential CRP titres showed a gradual decline with clinical improvement in both groups of patients. The IgM was unhelpful as it was raised (greater than or equal to 40 mg%) in 37 of the patients.

摘要

对患败血症和未患败血症的婴儿研究了以下非特异性感染指标

血红蛋白、白细胞总数、白细胞分类计数、血沉、血小板计数、C反应蛋白(CRP)、血清免疫球蛋白、血浆C3和触珠蛋白。对43例有败血症临床特征的低出生体重(LBW)婴儿进行了调查;血培养19例阳性,24例阴性。血培养阳性组死亡率为53%,阴性组为13%。两组婴儿比较显示,CRP滴度(用乳胶凝集法测定)是唯一可靠的非特异性感染指标。血培养阳性婴儿(16/19)CRP滴度升高的频率高于血培养阴性婴儿(7/17)(P<0.001)。血培养阳性新生儿CRP滴度(均值±2标准差)分别为15.75±12,血培养阴性新生儿为6.13±11.72(P<0.0004)。20例健康对照中有5例CRP滴度阳性(4±8.4)。两组患者连续的CRP滴度均随临床症状改善而逐渐下降。IgM无诊断价值,因为37例患者IgM升高(≥40mg%)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验